SPR Therapeutics' Series C Round

SPR Therapeutics raised a round of funding on September 12, 2017. Investors include Frontcourt Group.

SPR Therapeutics is a medical device company that is commercializing pain treatments utilizing its peripheral nerve stimulation (PNS) products. The company is developing a pipeline of neurostimulation…

Articles about SPR Therapeutics' Series C Round: